BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38547894)

  • 1. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
    Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
    Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
    Ipenburg NA; Nieweg OE; Ahmed T; van Doorn R; Scolyer RA; Long GV; Thompson JF; Lo S
    Br J Surg; 2019 Sep; 106(10):1319-1326. PubMed ID: 31310333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
    Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
    Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
    Verver D; van Klaveren D; Franke V; van Akkooi ACJ; Rutkowski P; Keilholz U; Eggermont AMM; Nijsten T; Grünhagen DJ; Verhoef C
    Br J Surg; 2019 Feb; 106(3):217-225. PubMed ID: 30307046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
    Tropea S; Del Fiore P; Maurichi A; Patuzzo R; Santinami M; Ribero S; Quaglino P; Caliendo V; Borgognoni L; Sestini S; Giudice G; Nacchiero E; Caracò C; Cordova A; Solari N; Piazzalunga D; Tauceri F; Carcoforo P; Lombardo M; Cavallari S; Mocellin S;
    BMC Cancer; 2022 Jun; 22(1):610. PubMed ID: 35659273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
    Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer N; Berking C; Sunderkötter C; Kaatz M; Schulte KW; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Martus P; Garbe C;
    Lancet Oncol; 2016 Jun; 17(6):757-767. PubMed ID: 27161539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
    Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
    Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.
    Walker RJB; Look Hong NJ; Moncrieff M; van Akkooi ACJ; Jost E; Nessim C; van Houdt WJ; Stahlie EHA; Seo C; Quan ML; McKinnon JG; Wright FC; Mavros MN
    Ann Surg Oncol; 2022 Oct; 29(11):7010-7017. PubMed ID: 35676603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
    Monroe MM; Pattisapu P; Myers JN; Kupferman ME
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
    Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.